{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:03:23Z","timestamp":1787796203408,"version":"build-2784847793"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006360","name":"Frankel Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00467-022-05692-1","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T02:02:27Z","timestamp":1658541747000},"page":"927-931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3711-8785","authenticated-orcid":false,"given":"Stuart L.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenar T.","family":"Yessayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli A.","family":"Krallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Westover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. David","family":"Humes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"5692_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MOP.0b013e32834ec9c1","volume":"24","author":"K Risma","year":"2012","unstructured":"Risma K, Jordan MB (2012) Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr 24:9\u201315","journal-title":"Curr Opin Pediatr"},{"key":"5692_CR2","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3389\/fimmu.2017.01902","volume":"8","author":"RA Marsh","year":"2017","unstructured":"Marsh RA (2017) Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis. Front Immunol 8:1902","journal-title":"Front Immunol"},{"key":"5692_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fped.2019.00071","volume":"7","author":"WY Kim","year":"2019","unstructured":"Kim WY, Montes-Mojarro IA, Fend F, Quintanilla-Martinez L (2019) Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases. Front Pediatr 7:71","journal-title":"Front Pediatr"},{"key":"5692_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nri2803","volume":"10","author":"BG de Saint","year":"2010","unstructured":"de Saint BG, Menasche G, Fischer A (2010) Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 10:568\u2013579","journal-title":"Nat Rev Immunol"},{"key":"5692_CR5","doi-asserted-by":"publisher","first-page":"e28581","DOI":"10.1002\/pbc.28581","volume":"67","author":"S Bami","year":"2020","unstructured":"Bami S, Vagrecha A, Soberman D, Badawi M, Cannone D, Lipton JM, Cron RQ, Levy CF (2020) The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 67:e28581","journal-title":"Pediatr Blood Cancer"},{"key":"5692_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","volume":"3","author":"DT Lounder","year":"2019","unstructured":"Lounder DT, Bin Q, de Min C, Jordan MB (2019) Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections. Blood Adv 3:47\u201350","journal-title":"Blood Adv"},{"key":"5692_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/MAT.0000000000001239","volume":"66","author":"L Yessayan","year":"2020","unstructured":"Yessayan L, Szamosfalvi B, Napolitano L, Singer B, Kurabayashi K, Song Y, Westover A, Humes HD (2020) Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy. ASAIO J 66:1079\u20131083","journal-title":"ASAIO J"},{"key":"5692_CR8","doi-asserted-by":"crossref","unstructured":"Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD (2011) A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One 6:e18584","DOI":"10.1371\/journal.pone.0018584"},{"key":"5692_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ekir.2017.12.012","volume":"3","author":"CJ Pino","year":"2018","unstructured":"Pino CJ, Westover AJ, Johnston KA, Buffington DA, Humes HD (2018) Regenerative Medicine and Immunomodulatory Therapy: Insights From the Kidney, Heart, Brain, and Lung. Kidney Int Rep 3:771\u2013783","journal-title":"Kidney Int Rep"},{"key":"5692_CR10","doi-asserted-by":"publisher","first-page":"e0694","DOI":"10.1097\/CCE.0000000000000694","volume":"4","author":"LT Yessayan","year":"2022","unstructured":"Yessayan LT, Neyra JA, Westover AJ, Szamosfalvi B, Humes HD (2022) Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients. Crit Care Explor 4:e0694","journal-title":"Crit Care Explor"},{"key":"5692_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ekir.2020.12.010","volume":"6","author":"SL Goldstein","year":"2021","unstructured":"Goldstein SL, Askenazi DJ, Basu RK, Selewski DT, Paden ML, Krallman KA, Kirby CL, Mottes TA, Terrell T, Humes HD (2021) Use of the Selective Cytopheretic Device in Critically Ill Children. Kidney Int Rep 6:775\u2013784","journal-title":"Kidney Int Rep"},{"key":"5692_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","volume":"368","author":"KA Brown","year":"2006","unstructured":"Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet 368:157\u2013169","journal-title":"Lancet"},{"key":"5692_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.biocel.2012.12.023","volume":"45","author":"A Ivetic","year":"2013","unstructured":"Ivetic A (2013) Signals regulating L-selectin-dependent leucocyte adhesion and transmigration. Int J Biochem Cell Biol 45:550\u2013555","journal-title":"Int J Biochem Cell Biol"},{"key":"5692_CR14","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4049\/jimmunol.168.3.1219","volume":"168","author":"R Li","year":"2002","unstructured":"Li R, Haruta I, Rieu P, Sugimori T, Xiong JP, Arnaout MA (2002) Characterization of a conformationally sensitive murine monoclonal antibody directed to the metal ion-dependent adhesion site face of integrin CD11b. J Immunol 168:1219\u20131225","journal-title":"J Immunol"},{"key":"5692_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1172\/JCI116587","volume":"92","author":"MK Whyte","year":"1993","unstructured":"Whyte MK, Hardwick SJ, Meagher LC, Savill JS, Haslett C (1993) Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro. J Clin Invest 92:446\u2013455","journal-title":"J Clin Invest"},{"key":"5692_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MAT.0000000000000400","volume":"62","author":"B Szamosfalvi","year":"2016","unstructured":"Szamosfalvi B, Westover A, Buffington D, Yevzlin A, Humes HD (2016) Immunomodulatory Device Promotes a Shift of Circulating Monocytes to a Less Inflammatory Phenotype in Chronic Hemodialysis Patients. ASAIO J 62:623\u2013630","journal-title":"ASAIO J"},{"key":"5692_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","volume":"382","author":"F Locatelli","year":"2020","unstructured":"Locatelli F, Jordan MB, Allen C, Cesaro S, Rizzari C, Rao A, Degar B, Garrington TP, Sevilla J, Putti MC, Fagioli F, Ahlmann M, Dapena Diaz JL, Henry M, De Benedetti F, Grom A, Lapeyre G, Jacqmin P, Ballabio M, de Min C (2020) Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. N Engl J Med 382:1811\u20131822","journal-title":"N Engl J Med"},{"key":"5692_CR18","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS (2020) Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol 2:e358\u2013e367","journal-title":"Lancet Rheumatol"},{"key":"5692_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10875-020-00789-4","volume":"40","author":"NJ Gloude","year":"2020","unstructured":"Gloude NJ, Dandoy CE, Davies SM, Myers KC, Jordan MB, Marsh RA, Kumar A, Bleesing J, Teusink-Cross A, Jodele S (2020) Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy. J Clin Immunol 40:699\u2013707","journal-title":"J Clin Immunol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05692-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:17:55Z","timestamp":1744143475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05692-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5692"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05692-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SLG consults for SeaStar Medical, Inc. HDH and AW report a financial interest in SeaStar Medical, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}